This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Jul;60(1):15-8.

doi: 10.1002/hep.27044.

Sorafenib use in hepatocellular carcinoma: more questions than answers

Ghassan K Abou-Alfa¹

Affiliations

Affiliation

¹ Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Internal Medicine, Weill Cornell Medical College, New York, NY.

PMID: 24493250
DOI: 10.1002/hep.27044

Editorial

Sorafenib use in hepatocellular carcinoma: more questions than answers

Ghassan K Abou-Alfa. Hepatology. 2014 Jul.

. 2014 Jul;60(1):15-8.

doi: 10.1002/hep.27044.

Author

Ghassan K Abou-Alfa¹

Affiliation

¹ Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Internal Medicine, Weill Cornell Medical College, New York, NY.

PMID: 24493250
DOI: 10.1002/hep.27044

No abstract available

PubMed Disclaimer

Comment on

Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy.
Iavarone M, Cabibbo G, Piscaglia F, Zavaglia C, Grieco A, Villa E, Cammà C, Colombo M; SOFIA (SOraFenib Italian Assessment) study group. Iavarone M, et al. Hepatology. 2011 Dec;54(6):2055-63. doi: 10.1002/hep.24644. Hepatology. 2011. PMID: 21898496

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information